Enlivex Therapeutics Ltd. (ENLV) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Enlivex Therapeutics Ltd.
Address
14 Einstein Street
Ness Ziona, TA 7403618
Israel
Phone
972 8 662 3301
Website
Sector
Healthcare
Industry
Biotechnology
Employees
34
First IPO Date
July 31, 2014
Key Executives
| Name | Title | Pay | Year Born |
| Oren Hershkovitz | Chief Executive Officer | 273,600 | 1977 |
| Shachar Shlosberger | Chief Financial Officer | 126,000 | 1977 |
| Dror Mevorach | Founder and Scientific Advisor | 180,000 | 1956 |
| Shai Novik | Executive Chairman | 528,000 | 1966 |
| Einat Galamidi | Chief Medical Officer | 0 | 1974 |
| Veronique Amor-Baroukh | Chief Operating Officer | 0 | N/A |
| Sigal Arad | Director of Human Resources | 0 | N/A |
AD
Description
Enlivex Therapeutics Ltd., established in 2005 and based in Nes Ziona, Israel, operates as a clinical-stage biotechnology firm dedicated to macrophage reprogramming immunotherapy. The company is currently advancing Allocetra, its flagship cell-based therapeutic. This treatment is undergoing Phase II clinical evaluation for its effectiveness in addressing organ dysfunction and failure that arises from sepsis. Additionally, Allocetra is being investigated in preclinical studies for its potential application in solid tumor therapy.
AD
